Coalition Letter To Senate HELP And Energy And Commerce Committee On User Fee Reauthorization Legislation

It is critically important that House and Senate committees work together to consolidate differences between the Food and Drug Amendments Act (H.R. 7667), which passed the House of Representatives on June 8, and the Food and Drug Administration Safety and Landmark Advancements Act (S. 4348), which passed the Senate Health, Education, Labor, and Pensions (HELP) Committee on June 15.

Coalition Letter To Senate HELP And Energy And Commerce Committee On User Fee Reauthorization Legislation Read More »